The environmentally-friendly strategy offers major advantages over existing methods
Initial demonstrations yield compounds with promise for treating COPD, cystic fibrosis, and other lung disorders
CURRENT ISSUE - October 2025
Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature